Isracann Biosciences Launches Phase One Facility Development Program in Israel
28 oct. 2019 00h01 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is...